EditorialBPOG Special Section
Microbial Monitoring For Biological Drug Substance Manufacturing: An Industry Perspective
David Bain, Diane Hardy, Brian L. Bell, Ren-Yo Forng, Michael Knight, Anita Bawa, Stephanie Ramsey, Christine Arbesser-Rastburg, Mousumi Paul, Christopher Ton, Fran Leira, Claudia Roman, Kim McFarland, David Phillips, Jean Stuckey, Christian Bauer and Andres J. Calvo
PDA Journal of Pharmaceutical Science and Technology May 2015, 69 (3) 451-460; DOI: https://doi.org/10.5731/pdajpst.2015.01070
David Bain
Roles: Facilitator, BPOG
Diane Hardy
Roles: Chief Microbiologist, Regeneron
Brian L. Bell
Roles: Senior Scientist, Bristol-Myers Squibb
Ren-Yo Forng
Roles: Site Microbiologist, Astra Zeneca
Michael Knight
Roles: Senior Manager, QC Microbiology, Genentech
Anita Bawa
Roles: Director, QC, Bayer
Stephanie Ramsey
Roles: Manager, Quality Systems, Baxter
Christine Arbesser-Rastburg
Roles: Director Quality Operations/Microbiology, Baxter
Mousumi Paul
Roles: Associate Director, Engineering, Merck
Christopher Ton
Roles: Associate Director, Merck
Fran Leira
Roles: Global MSAT/QC Head, Lonza
Claudia Roman
Roles: Site Head, QC, Microbiology, GlaxoSmithKline
Kim McFarland
Roles: Director, QC Microbiology, Alexion
David Phillips
Roles: Senior Director, QC, Shire
Jean Stuckey
Roles: Manager, QC, Microbiology/Lab Services, Patheon
Christian Bauer
Roles: Head of Biotech Compliance and Projects, Sanofi
Andres J. Calvo
Roles: Senior Scientist, AbbVie

Article Information
vol. 69 no. 3 451-460
PubMed
Published By
Print ISSN
Online ISSN
History
- Published online June 4, 2015.
Copyright & Usage
© PDA, Inc. 2015
Author Information
Cited By...
This article has been cited by the following articles in journals that are participating in Crossref Cited-by Linking.
- Luciana Veloso da Costa, Rebeca Vitoria da Silva Lage de Miranda, Cristhiane Moura Falavina dos Reis, Joyce Modesto de Andrade, Fernanda Ventura Cruz, Adriana Marques Frazão, Erica Louro da Fonseca, Juliana Nunes Ramos, Marcelo Luiz Lima Brandão, Verônica Viana VieiraJournal of Microbiological Methods 2022 203
- Magnus Wetterhall, Anna Grönberg, Sara Grönlund, Tomas Björkman, Lena Sandberg, Sravani Musunuri, Katherine Chaloupka, Patrick GammellJournal of Chromatography B 2019 1118-1119
- Rebeca Vitória da Silva Lage de Miranda, Luciana Veloso da Costa, Letícia de Sousa Albuquerque, Cristhiane Moura Falavina dos Reis, Lygia Maria Paulo da Silva Braga, Joyce Modesto de Andrade, Juliana Nunes Ramos, Josiane Machado Vieira Mattoso, Stephen James Forsythe, Marcelo Luiz Lima BrandãoLetters in Applied Microbiology 2023 76 5
- Leon P. Pybus, Charles Heise, Tibor Nagy, Carmen Heeran, Terri Dover, John Raven, Junichi Kori, Graeme Burton, Hiroshi Sakuyama, Benjamin Hastings, Michelle Lyons, Shinichi Nakai, Jonathan HaighBiotechnology Progress 2024 40 4
- Shoji Narutaki, Ineui Lee, Yasuhito Sugawara, Kahei Akada, Akihiko KondoBiologicals 2020 66
- Lynn Johnson, Christoph Hansy, Hilary Chan2023
In This Issue
PDA Journal of Pharmaceutical Science and Technology
Vol. 69, Issue 3
May/June 2015
Microbial Monitoring For Biological Drug Substance Manufacturing: An Industry Perspective
David Bain, Diane Hardy, Brian L. Bell, Ren-Yo Forng, Michael Knight, Anita Bawa, Stephanie Ramsey, Christine Arbesser-Rastburg, Mousumi Paul, Christopher Ton, Fran Leira, Claudia Roman, Kim McFarland, David Phillips, Jean Stuckey, Christian Bauer, Andres J. Calvo
PDA Journal of Pharmaceutical Science and Technology May 2015, 69 (3) 451-460; DOI: 10.5731/pdajpst.2015.01070
Microbial Monitoring For Biological Drug Substance Manufacturing: An Industry Perspective
David Bain, Diane Hardy, Brian L. Bell, Ren-Yo Forng, Michael Knight, Anita Bawa, Stephanie Ramsey, Christine Arbesser-Rastburg, Mousumi Paul, Christopher Ton, Fran Leira, Claudia Roman, Kim McFarland, David Phillips, Jean Stuckey, Christian Bauer, Andres J. Calvo
PDA Journal of Pharmaceutical Science and Technology May 2015, 69 (3) 451-460; DOI: 10.5731/pdajpst.2015.01070
Jump to section
- Article
- Introduction
- Scope
- Background
- In-process Product Stream Monitoring and Testing
- Inoculum Expansion Operations
- Microbial Test Methods
- Setting Bioburden Control Levels (Alert/Action)
- Objectionable Organisms
- Responding To Bioburden Excursions
- Assessing Impact To Product Quality
- Conclusion
- Acknowledgements
- Footnotes
- References
- Figures & Data
- References
- Info & Metrics
Related Articles
- No related articles found.
Cited By...
- Quantitative and Qualitative Evaluation of Microorganism Profile Identified in Bioburden Analysis in a Biopharmaceutical Facility in Brazil: Criteria for Classification and Management of Results
- Risk-Based Selection of Environmental Classifications for Biopharmaceutical Operations
- Mold Control and Detection in Biological Drug Substance Manufacturing Facilities: An Industry Perspective